These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 18302099

  • 21. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF).
    Vlahos R, Bozinovski S, Hamilton JA, Anderson GP.
    Pharmacol Ther; 2006 Oct; 112(1):106-15. PubMed ID: 16716406
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Cytokines and proteases involved in pathogenesis of COPD].
    Yamaya A, Osanai K.
    Nihon Rinsho; 2011 Oct; 69(10):1748-53. PubMed ID: 22073567
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB.
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [Abstract] [Full Text] [Related]

  • 26. Current aspects in etiopathogenesis and diagnosis of chronic obstructive pulmonary disease.
    Leru P.
    Rom J Intern Med; 2004 Aug; 42(1):83-93. PubMed ID: 15529597
    [Abstract] [Full Text] [Related]

  • 27. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.
    Kanazawa H.
    Med Sci Monit; 2007 Nov; 13(11):RA189-195. PubMed ID: 17968307
    [Abstract] [Full Text] [Related]

  • 28. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence.
    Sinden NJ, Stockley RA.
    Thorax; 2010 Oct; 65(10):930-6. PubMed ID: 20627907
    [Abstract] [Full Text] [Related]

  • 29. The pathogenesis of COPD: lessons learned from in vivo animal models.
    Fujita M, Nakanishi Y.
    Med Sci Monit; 2007 Feb; 13(2):RA19-24. PubMed ID: 17261992
    [Abstract] [Full Text] [Related]

  • 30. Systemic effects of COPD.
    Decramer M, De Benedetto F, Del Ponte A, Marinari S.
    Respir Med; 2005 Dec; 99 Suppl B():S3-10. PubMed ID: 16219454
    [Abstract] [Full Text] [Related]

  • 31. [Pathogenesis of chronic obstructive pulmonary disease. Molecular mechanisms (part II)].
    Szulakowski P, Mróz RM, Pierzchała W, Chyczewska E, MacNee W.
    Wiad Lek; 2006 Dec; 59(3-4):250-4. PubMed ID: 16813274
    [Abstract] [Full Text] [Related]

  • 32. [Apoptosis in chronic obstructive pulmonary disease].
    Nagai A.
    Nihon Rinsho; 2003 Dec; 61(12):2126-32. PubMed ID: 14674321
    [Abstract] [Full Text] [Related]

  • 33. Killer cells in chronic obstructive pulmonary disease.
    Fairclough L, Urbanowicz RA, Corne J, Lamb JR.
    Clin Sci (Lond); 2008 Apr; 114(8):533-41. PubMed ID: 18336369
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. New treatments for chronic obstructive pulmonary disease.
    Barnes PJ.
    Ann Ist Super Sanita; 2003 Apr; 39(4):573-82. PubMed ID: 15098577
    [Abstract] [Full Text] [Related]

  • 36. Cells, mediators and Toll-like receptors in COPD.
    Sarir H, Henricks PA, van Houwelingen AH, Nijkamp FP, Folkerts G.
    Eur J Pharmacol; 2008 May 13; 585(2-3):346-53. PubMed ID: 18410916
    [Abstract] [Full Text] [Related]

  • 37. No evidence of chromosome damage in chronic obstructive pulmonary disease (COPD).
    Casella M, Miniati M, Monti S, Minichilli F, Bianchi F, Simi S.
    Mutagenesis; 2006 Mar 13; 21(2):167-71. PubMed ID: 16567348
    [Abstract] [Full Text] [Related]

  • 38. [The role of inflammation in the pathogenesis of chronic obstructive pulmonary disease].
    Chorostowska-Wynimko J.
    Pol Merkur Lekarski; 2004 Sep 13; 17(99):203-7. PubMed ID: 15628040
    [Abstract] [Full Text] [Related]

  • 39. Small airways: an important but neglected target in the treatment of obstructive airway diseases.
    Sturton G, Persson C, Barnes PJ.
    Trends Pharmacol Sci; 2008 Jul 13; 29(7):340-5. PubMed ID: 18514920
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.